Clinical Trials Logo

Ruptured Aneurysm clinical trials

View clinical trials related to Ruptured Aneurysm.

Filter by:
  • None
  • Page 1

NCT ID: NCT04499508 Recruiting - Clinical trials for Intracranial Aneurysm

Appraising the Embolization of Aneurysms Using Balt Optima™ Coil System (APPLY Study)

APPLY
Start date: April 10, 2020
Phase: N/A
Study type: Interventional

In recent years, many developments have been made to the tools and techniques used to treat IAs via endovascular intervention. Specifically, to the detachable coils themselves. In March 2018, the US Food and Drug administration granted Balt USA 510(k) clearance for the Optima Coil System™. Earlier this year, the list of devices included within the system has expanded to include OptiMAX Complex Super Soft and Complex Soft coils. It consists of coils that come in Standard, Soft and Super Soft profiles and allows for instant detachment from the pusher. The APPLY study is a prospective, single-center investigator-initiated study meant to assess the use of the Balt Optima™ Coil System. The site is looking to enroll approximately 30 subjects over the course of two years. The Optima Coil System™ is commercially available in the United States as such this study is looking for real-world data.

NCT ID: NCT04391803 Recruiting - Clinical trials for Intracranial Aneurysm

EvaLuate EndoVascular Treatment of Acutely Ruptured Shallow Intradural Aneurysms With the Pipeline™ Flex Embolization Device With Shield TEchnology™ (ELEVATE)

ELEVATE
Start date: May 6, 2022
Phase: N/A
Study type: Interventional

The purpose of the study is to assess the safety and effectiveness of the Pipeline™ Flex Embolization Device with Shield Technology™ in the treatment with acutely ruptured intracranial aneurysms.

NCT ID: NCT03408379 Active, not recruiting - Clinical trials for Intracranial Aneurysms

Impact of Platelet Activation in Intracranial Aneurysm Rupture Risk - PLAQRAN

PLAQRAN
Start date: December 20, 2017
Phase:
Study type: Observational

Sub arachnoid hemorrhage consecutive to intracranial aneurysm rupture is a devastating disease. Predictors of intracranial aneurysm rupture are limited and focus mainly on size and location. Platelet activation may have a deleterious role on aneurysm rupture. The assumption is that patients with ruptured intracranial aneurysm will present a higher rate of platelet activation compared to patients with non ruptured aneurysms.

NCT ID: NCT03252314 Recruiting - Ruptured Aneurysm Clinical Trials

Ruptured Aneurysms Treated With Hydrogel Coils

RAGE
Start date: November 27, 2017
Phase:
Study type: Observational

To determine safety and occlusion rates when second-generation hydrogel coils are used in the treatment of ruptured intracranial aneurysms.

NCT ID: NCT02864940 Terminated - Clinical trials for Subarachnoid Hemorrhage

Memory Training in Aneurysmal Subarachnoid Hemorrhage Patients

MASH
Start date: June 2016
Phase: N/A
Study type: Interventional

The study aim is to determine if periodic online cognitive exercises (Lumosity) improve memory function in ruptured cerebral aneurysm patients with disabling baseline memory deficits within the first 24 months after rupture. Half of the subjects will be randomized to use Lumosity-designed online cognitive exercises and half will serve as an active control group performing online crossword puzzles.